Patent details

Basic Information

Publication number:

EP3435996

PCT Application Number:

EP2017057634

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP177133329

PCT Publication Number:

WO2017167935

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ELAFIBRANOR FOR USE IN THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS

French Title of Invention:

ELAFIBRANOR POUR L'UTILISATION DANS LE TRAITEMENT DE LA CHOLANGITE BILIAIRE PRIMITIVE

German Title of Invention:

ELAFIBRANOR ZUR VERWENDUNG BEI DER BEHANDLUNG DER PRIMÄREN BILIÄREN CHOLANGITIS

SPC Number:

Dates

Filing date:

30/03/2017

Grant date:

30/04/2025

EP Publication Date:

06/02/2019

PCT Publication Date:

05/10/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/04/2025

EP B1 Publication Date:

30/04/2025

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

30/03/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/04/2025

 

 

Name:

Genfit

Address:

885, Avenue Eugène Avinée, 59120 Loos, France (FR)

Inventor

Name:

HANF, Rémy

Address:

France (FR)

Priority

Priority Number:

16305381

Priority Date:

31/03/2016

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 31/192; A61P 1/16; A61K 9/00; A61K 45/06;

Publication

European Patent Bulletin

Issue number:

202518

Publication date:

30/04/2025

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

31/03/2026

Annual Fee Number:

10

Annual Fee Amount:

131 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages